#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11332	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	521.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	627	C,T	607,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11332	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	521.6	0	HET	.	.	.	C519T	.	519	519	C	750	750	C	612	C,T	470,128	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20954	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3436	605.0	0	.	n	.	0	T695C	SNP	695	695	T	962	962	C	628	C,T	618,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20954	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3436	605.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1604	1604	A	711	A	699	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20954	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3436	605.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2238	2238	C	649	C,T,A	626,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20954	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3436	605.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2864	2864	T	610	T	597	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20954	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3436	605.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2312	2312	A	701	A	686	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20954	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3436	605.0	0	HET	.	.	.	G540A	.	540	540	G	807	807	G	730	G,A	540,156	.	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1440	folP	852	852	100.0	folP.l6.c4.ctg.1	1409	101.2	1	SNP	p	R228S	1	.	.	682	684	AGC	932	934	AGC	140;140;141	A;G;C	139;138;139	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3944	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	116.0	1	SNP	p	S91F	0	.	.	271	273	TCC	630	632	TCC	153;154;153	T;C;C	150;152;149	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3944	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	116.0	1	SNP	p	D95N	0	.	.	283	285	GAC	642	644	GAC	162;164;163	G;A;C	159;161;161	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3944	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	116.0	1	SNP	p	D95G	0	.	.	283	285	GAC	642	644	GAC	162;164;163	G;A;C	159;161;161	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1258	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1329	94.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	425	427	ACC	143;143;142	A;C;C	137;139;137	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1258	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1329	94.1	0	.	p	.	0	R44H	NONSYN	130	132	CGC	440	442	CAC	133;131;130	C;A;C	130;125;126	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1258	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1329	94.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	623	625	CAC	161;159;160	C;A;C	155;152;154	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1258	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1329	94.1	1	SNP	p	G45D	0	.	.	133	135	GGC	443	445	GGC	130;130;130	G;G;C	125;126;126	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	674	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1026	65.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3750	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3012	123.7	1	SNP	p	D86N	0	.	.	256	258	GAC	620	622	GAC	137;138;139	G;A;C	133;133;136	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3750	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3012	123.7	1	SNP	p	S87I	0	.	.	259	261	AGT	623	625	AGT	140;141;140	A;G;T,G	136;137;136,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3750	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3012	123.7	1	SNP	p	S87W	0	.	.	259	261	AGT	623	625	AGT	140;141;140	A;G;T,G	136;137;136,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3750	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3012	123.7	1	SNP	p	S87R	0	.	.	259	261	AGT	623	625	AGT	140;141;140	A;G;T,G	136;137;136,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3750	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3012	123.7	1	SNP	p	S88P	0	.	.	262	264	TCC	626	628	TCC	139;140;139	T;C;C	134;137;134	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3182	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2517	125.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1485	1487	GGC	170;165;164	G;G;C	164;161;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1193	1195	GCA	153;154;156	G;C;A	148;150;153	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1196	1198	ATC	157;157;157	A;T,C;C	151;153,1;151	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1208	1210	GTG	161;163;167	G;T;G	157;158;163	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1208	1210	GTG	161;163;167	G;T;G	157;158;163	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1712	1714	ACC	159;159;158	A;C;C	150;155;152	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1766	1768	GCG	143;137;142	G;C,G;G	131;119,2;123	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1766	1768	GCG	143;137;142	G;C,G;G	131;119,2;123	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1889	1891	GGC	115;114;110	G;G;C	109;108;105	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1898	1900	GGC	104;98;98	G;G;C	99;92;94	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3010	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2200	134.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1916	1918	CCG	82;84;80	C,T;C;G,C	75,1;80;69,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4142	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3078	133.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1830	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1929	93.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	604	604	C	130	C	122	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	501	503	GGA	167;170;172	G;G;A	161;165;166	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	762	764	CTT	146;145;147	C;T;T	142;140;140	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	786	788	GGA	145;145;146	G;G;A	141;142;137	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	0	.	p	.	0	D171G	NONSYN	511	513	GAT	870	872	GGT	154;153;152	G;G;T	150;150;138	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	0	.	p	.	0	G189S	NONSYN	565	567	GGC	924	926	AGC	153;153;154	A;G;C	150;145;149	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	990	990	T	143	T	136	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	1	SNP	p	G120K	0	.	.	358	360	GGT	717	719	GGT	146;143;142	G;G;T	142;141;135	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	1	SNP	p	A121N	0	.	.	361	363	GCC	720	722	GCC	140;140;142	G;C;C	137;139;139	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2052	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1623	125.5	1	SNP	p	A121D	0	.	.	361	363	GCC	720	722	GCC	140;140;142	G;C;C	137;139;139	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7474	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4780	155.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2001	2003	AAT	143;141;143	A;A;T	139;136;139	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	824	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1113	73.6	1	SNP	p	V57M	1	.	.	169	171	ATG	558	560	ATG	155;153;154	A;T;G	147;149;150	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
